The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 129 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Antihypertensive Agents  [Clear All Filters]
2023
Georgianos, P. I., Tziatzios G., Roumeliotis S., Vaios V., Sgouropoulou V., Tsalikakis D. G., et al. (2023).  Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis.. Nephrol Dial Transplant. 38(1), 203-211.
2022
Vareta, G., Georgianos P. I., Vaios V., Sgouropoulou V., Georgianou E. I., Leivaditis K., et al. (2022).  Prevalence of Apparent Treatment-Resistant Hypertension in ESKD Patients Receiving Peritoneal Dialysis.. Am J Hypertens. 35(11), 918-922.
2020
Pisano, A., Bolignano D., Mallamaci F., D'Arrigo G., Halimi J-M., Persu A., et al. (2020).  Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis.. Nephrol Dial Transplant. 35(5), 878-887.
Loutradis, C., & Sarafidis P. (2020).  Pharmacotherapy of hypertension in patients with pre-dialysis chronic kidney disease.. Expert Opin Pharmacother. 21(10), 1201-1217.
2019
Loutradis, C., Papadopoulou E., Theodorakopoulou M., Karagiannis A., & Sarafidis P. (2019).  The effect of SGLT-2 inhibitors on blood pressure: a pleiotropic action favoring cardio- and nephroprotection.. Future Med Chem. 11(11), 1285-1303.
Bikos, A., Loutradis C., Angeloudi E., Karpetas A., Raptis V., Kalaitzidis R., et al. (2019).  The effects of nebivolol and irbesartan on postdialysis and ambulatory blood pressure in patients with intradialytic hypertension: a randomized cross-over study.. J Hypertens. 37(2), 432-442.
Georgianos, P. I., Liakopoulos V., & Zebekakis P. E. (2019).  Low-dose combination therapy to control sustained ambulatory hypertension-Basic principles and future directions.. J Clin Hypertens (Greenwich). 21(2), 249-251.
Loutradis, C., Bikos A., Raptis V., Afkou Z., Tzanis G., Pyrgidis N., et al. (2019).  Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension.. Hypertens Res. 42(7), 1001-1010.
Sarafidis, P. A., Mallamaci F., Loutradis C., Ekart R., Torino C., Karpetas A., et al. (2019).  Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA.. Nephrol Dial Transplant. 34(9), 1542-1548.
2018
Georgianou, E., Georgianos P. I., Petidis K., Athyros V. G., Sarafidis P. A., & Karagiannis A. (2018).  Antihypertensive therapy in acute ischemic stroke: where do we stand?. J Hum Hypertens. 32(12), 799-807.
Georgianos, P. I., Pikilidou M. I., Liakopoulos V., Balaskas E. V., & Zebekakis P. E. (2018).  Arterial stiffness in end-stage renal disease-pathogenesis, clinical epidemiology, and therapeutic potentials.. Hypertens Res. 41(5), 309-319.
Sarafidis, P. A., Ruilope L. M., Loutradis C., Gorostidi M., de la Sierra A., de la Cruz J. J., et al. (2018).  Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients.. J Hypertens. 36(5), 1076-1085.
Antza, C., Doundoulakis I., Stabouli S., & Kotsis V. (2018).  Comparison Among Recommendations for the Management of Arterial Hypertension Issued by Last US, Canadian, British and European Guidelines.. High Blood Press Cardiovasc Prev. 25(1), 9-16.
Mitsiou, E., Boutari C., Kotsis V., Georgianou E., Doumas M., Karagiannis A., et al. (2018).  Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension.. Curr Vasc Pharmacol. 16(4), 393-400.
Papadopoulou, E., Angeloudi E., Karras S., & Sarafidis P. (2018).  The optimal blood pressure target in diabetes mellitus: a quest coming to an end?. J Hum Hypertens. 32(10), 641-650.
Founti, P., Coleman A. L., M Wilson R., Yu F., Anastasopoulos E., Harris A., et al. (2018).  Overdiagnosis of open-angle glaucoma in the general population: the Thessaloniki Eye Study.. Acta Ophthalmol. 96(7), e859-e864.
Konstas, A-G., Katsanos A., Athanasopoulos G. P., Voudouragkaki I. C., Panagiotou E. S., Pagkalidou E., et al. (2018).  Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients.. Expert Opin Pharmacother. 19(18), 1981-1988.
2017
Konstas, A-G., Boboridis K. G., Kapis P., Marinopoulos K., Voudouragkaki I. C., Panayiotou D., et al. (2017).  24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe. Adv Ther. 34(1), 221-235.
Kalouda, P., Keskini C., Anastasopoulos E., & Topouzis F. (2017).  Achievements and Limits of Current Medical Therapy of Glaucoma.. Dev Ophthalmol. 59, 1-14.
Liakos, C. I., Papadopoulos D. P., & Kotsis V. T. (2017).  Adherence to Treatment, Safety, Tolerance, and Effectiveness of Perindopril/Amlodipine Fixed-Dose Combination in Greek Patients with Hypertension and Stable Coronary Artery Disease: A Pan-Hellenic Prospective Observational Study of Daily Clinical Practice. Am J Cardiovasc Drugs. 17(5), 391-398.
Sarafidis, P. A., Lazaridis A. A., Ruiz-Hurtado G., & Ruilope L. M. (2017).  Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME.. Nat Rev Endocrinol. 13(6), 365-374.
Loutradis, C. N., Tsioufis C., & Sarafidis P. A. (2017).  The Clinical Problems of Hypertension Treatment in Hemodialysis Patients.. Curr Vasc Pharmacol. 16(1), 54-60.
Doumas, M., Boutari C., Tsioufis C., Dimitriadis K., Triantafyllou A., & Douma S. (2017).  Clinical Value of Measuring the Renin/Aldosterone Levels: Optimising the Management of Uncontrolled/Resistant Hypertension.. Curr Vasc Pharmacol. 16(1), 10-14.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2017).  Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke.. Clin Exp Hypertens. 39(3), 246-250.
Sarafidis, P. A., Persu A., Agarwal, iv R., Burnier M., de Leeuw P., Ferro C. J., et al. (2017).  Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidne. Nephrol Dial Transplant. 32(4), 620-640.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.